-
Diagnostics World | Harry Glorikian’s new book, Commercializing Novel IVDs: A Comprehensive Manual for Success, provides an overview of the IVD landscape today, from IVD conception through commercialization.
Feb 3, 2017
-
American Council On Science And Health |
The ACMG recently published a statement discussing genome editing in clinical genetics. They discuss various topics, such as the limitations of genome editing technologies, and technical concerns.
Feb 1, 2017
-
Forbes |
Aiming to tackle the severe shortage of specialist doctors in India, the 27-year olds behind the DocsApp platform promise a consultation with a doctor within 30 minutes of logging on to their app (with a little AI help).
Jan 30, 2017
-
Diagnostics World Brief | Illumina today announced that it has declared conformity with the requirements of the IVD Directive and has applied the CE mark to an expanded VeriSeq NIPT Analysis Software for clinical laboratories in the European Union.
Jan 30, 2017
-
Diagnostics World Brief | News, products, and partnerships from around the diagnostics community including news from Illumina, Mobidiag, Omicia, and more.
Jan 26, 2017
-
Diagnostics World | Newly out of stealth mode, Two Pore Guys is seeking diagnostic partners for its silicon pore detection platform.
Jan 23, 2017
-
MIT Technology Review |
More than half of pediatric cancer patients have genetic faults that could affect their diagnosis or be targeted by drugs.
Jan 23, 2017
-
Forbes |
Diagnosing serious diseases and conditions via just listening to voice snippets is possible. Are we about to get a doctor in every room thanks to Alexa, Siri and Google Home?
Jan 23, 2017
-
Diagnostics World Brief | Roche announced that it has received the 510(k) clearance for its Elecsys Troponin T Gen 5 STAT blood test for patients with a suspected heart attack. Roche is now the first IVD company in the U.S. to provide the next generation Troponin testing for patients as an aid in the diagnosis of myocardial infarction.
Jan 20, 2017
-
Diagnostics World | Researchers have recently developed technology that is able to screen anticancer drugs inside tumors for their therapeutic potency. 100 nanometer liposomes were loaded with minuscule amounts of chemotherapeutics and synthetic DNA strands, or “barcodes,” that identify the therapeutics.
Jan 19, 2017
-
Forbes |
Google veteran Adrian Aoun has raised more than $30 million to create a new kind of tech-enabled medical practice that hopes to deliver better care at lower cost.
Jan 17, 2017
-
MIT Technology Review |
A strain of bacteria resistant to 26 different antibiotics killed a woman in Nevada, a stark warning that humanity continues to lose ground in the fight against antibiotic resistance.
Jan 13, 2017
-
Diagnostics World | Experts weigh in on the evolution of a whole new healthcare experience.
Jan 12, 2017
-
Diagnostics World News | In a new article on the American Association for Cancer Research’s blog, Charles Sawyers went into detail about the recent developments the AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) has launched, including releasing one of the largest fully public cancer genomic data sets to date.
Jan 11, 2017
-
Bio-IT World |
An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.
Jan 9, 2017
-
Diagnostics World News | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.
Jan 9, 2017
-
Diagnostics World Brief | Two Pore Guys today announced the company is collaborating with oncologists at UCSF, to evaluate its handheld nanopore-based platform in the detection of cell-free, ctDNA from patient liquid biopsies.
Jan 6, 2017
-
Diagnostics World Brief | Foundation Medicine today announced that, as part of the succession of its executive leadership, the Board of Directors has appointed Troy Cox, a highly regarded global biopharma leader, as chief executive officer to succeed Michael Pellini.
Jan 6, 2017
-
Diagnostics World Brief | Human Longevity, Inc. today announced Cynthia Collins as the new Chief Executive Officer effective January 9, 2017. Collins, who has a successful track record and extensive leadership experience in the life sciences sector, will lead HLI and be responsible for all functions of the company including commercialization of HLI key products and strategic operations. She will also join the Board of Directors.
Jan 4, 2017
-
Diagnostics World News Brief | Illumina today announced it has named one of the world’s top clinical genomis experts to head its clinical genomics unit. Garret Hampton will join as Executive Vice President of Clinical Genomics for the company, starting January 9, 2017.
Jan 3, 2017